pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
766
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 1
ASC-930
Graft Versus Host Disease (GVHD)
ASC Therapeutics Inc
0
catalysts
Phase 1
ASD-141
Solid Tumor
Ascendo Biotechnology Inc
0
catalysts
Phase 1
AST-021p
Epithelial Ovarian Cancer
Aston Sci Inc
0
catalysts
Phase 1
AST-201
← prev
page 4 of 26
next →
131
Pain
89
Neurology
1
Ovarian Cancer
EpiThany Inc
0
catalysts
Phase 1
AT-0365
Breast Cancer
Axcynsis Therapeutics Pte Ltd
0
catalysts
Phase 1
AT-7687
Obesity
Antag Therapeutics ApS
0
catalysts
Phase 1
ATA-100
Limb-Girdle Muscular Dystrophy
Atamyo Therapeutics SAS
0
catalysts
Phase 1
ATA-2271
Malignant Pleural Mesothelioma
Memorial Sloan Kettering Cancer Center
0
catalysts
Phase 1
ATCell
Traumatic Brain Injury
American CryoStem Corp
0
catalysts
Phase 1
ATG-031
B-Cell Non-Hodgkin Lymphoma
Antengene Corp Ltd
0
catalysts
Phase 1
ATH-1020
Neurodegenerative Diseases
$LONA
LeonaBio, Inc.
0
catalysts
Phase 1
ATH-1105
Amyotrophic Lateral Sclerosis
$LONA
LeonaBio, Inc.
0
catalysts
Phase 1
ATH-399A
Parkinson's Disease
NurrOn Pharmaceuticals Inc
0
catalysts
Phase 1
ATI-1013
Thromboangiitis obliterans (Buerger disease)
Antidote Therapeutics Inc
0
catalysts
Phase 1
ATR-12
Netherton Syndrome (Bamboo Hair)
$AZTR
Azitra, Inc.
0
catalysts
Phase 1
AU-409
Bile Duct Cancer (Cholangiocarcinoma)
Auransa Inc
0
catalysts
Phase 1
AUG-801
Congenital Disorder of Glycosylation
AUG Therapeutics LLC
0
catalysts
Phase 1
AUR-200
Systemic Lupus Erythematosus
$AUPH
Aurinia Pharmaceuticals Inc.
0
catalysts
Phase 1
AUT-00201
Myoclonic Seizure
Autifony Therapeutics Ltd
0
catalysts
Phase 1
AUT-00206
Fragile X Syndrome
Autifony Therapeutics Ltd
0
catalysts
Phase 1
AUTX-703
Myelodysplastic Syndrome (Preleukemia)
Auron Therapeutics Inc
0
catalysts
Phase 1
AV-1959D
Alzheimer's Disease
Nuravax Inc
0
catalysts
Phase 1
AV-203
Bladder Cancer
Receptor tyrosine-protein kinase erbB-3
AVEO Pharmaceuticals Inc
0
catalysts
Phase 1
AVA-6103
Adenocarcinoma Of The Gastroesophageal Junction
Avacta Life Sciences Ltd
0
catalysts
Phase 1
AZD-8965
Idiopathic Pulmonary Fibrosis
$AZN
ASTRAZENECA PLC
0
catalysts
Phase 1
B-2318
Dementia Associated With Alzheimer's Disease
Bostal Drug Delivery Co Ltd
0
catalysts
Phase 1
BAL-0891
Adenocarcinoma Of The Gastroesophageal Junction
Sillajen Biotherapeutics
0
catalysts
Phase 1
BBI-940
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
$BOLD
Boundless Bio, Inc.
0
catalysts
Phase 1
BBO-11818
Pancreatic Ductal Adenocarcinoma
$BBOT
BridgeBio Oncology Therapeutics, Inc.
0
catalysts
Phase 1
BBO-8520
Metastatic Colorectal Cancer
$BBOT
BridgeBio Oncology Therapeutics, Inc.
0
catalysts
